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Abstract
8,59 cyclopurine deoxynucleosides (cPu) are locally distorting DNA base lesions corrected by nucleotide excision repair (NER)
and proposed to play a role in neurodegeneration prevalent in genetically defined Xeroderma pigmentosum (XP) patients.
In the current study, purified recombinant helicases from different classifications based on sequence homology were
examined for their ability to unwind partial duplex DNA substrates harboring a single site-specific cPu adduct. Superfamily
(SF) 2 RecQ helicases (RECQ1, BLM, WRN, RecQ) were inhibited by cPu in the helicase translocating strand, whereas helicases
from SF1 (UvrD) and SF4 (DnaB) tolerated cPu in either strand. SF2 Fe-S helicases (FANCJ, DDX11 (ChlR1), DinG, XPD)
displayed marked differences in their ability to unwind the cPu DNA substrates. Archaeal Thermoplasma acidophilum XPD
(taXPD), homologue to the human XPD helicase involved in NER DNA damage verification, was impeded by cPu in the non-
translocating strand, while FANCJ was uniquely inhibited by the cPu in the translocating strand. Sequestration experiments
demonstrated that FANCJ became trapped by the translocating strand cPu whereas RECQ1 was not, suggesting the two SF2
helicases interact with the cPu lesion by distinct mechanisms despite strand-specific inhibition for both. Using a protein trap
to simulate single-turnover conditions, the rate of FANCJ or RECQ1 helicase activity was reduced 10-fold and 4.5-fold,
respectively, by cPu in the translocating strand. In contrast, single-turnover rates of DNA unwinding by DDX11 and UvrD
helicases were only modestly affected by the cPu lesion in the translocating strand. The marked difference in effect of the
translocating strand cPu on rate of DNA unwinding between DDX11 and FANCJ helicase suggests the two Fe-S cluster
helicases unwind damaged DNA by distinct mechanisms. The apparent complexity of helicase encounters with an unusual
form of oxidative damage is likely to have important consequences in the cellular response to DNA damage and DNA repair.
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Introduction
Oxidative DNA damage represented by a spectrum of bases or
sugar modifications is incurred by reactive oxygen species that
arise from endogenous biochemical processes and can also be
induced exogenously by environmental agents such as chemical
compounds (e.g., aldehydes, peroxides) or ionizing radiation.
Oxidative DNA lesions in nuclear and/or mitochondrial genomes
result in perturbations to cellular DNA replication and transcrip-
tion; furthermore, their accumulation predisposes individuals to
accelerated tissue aging, neurodegeneration, and cancer. A variety
of oxidative DNA lesions exist, and recent efforts have focused on
establishing meaningful relationships between the accumulation of
a particular oxidative lesion and aberrant cellular and organismal
phenotypes as well as the pathways for repairing and tolerating the
spectrum of oxidative DNA lesions [1].
A class of endogenous oxidative DNA lesions that has attracted
considerable attention for potential roles in human disease and
mutagenesis is 8,59-cyclopurine-29-deoxynucleoside (cPu) [2]. The
occurrence of cyclopurines in affected tissues may serve as a
biomarker for disease or cancer risk, and effectiveness of
therapeutic drugs [3,4]. The cPu DNA lesion arises from hydroxyl
radical attack of the H5-atom of the sugar moiety leading to a
carbon centered radical that reacts with the C8 position of the
purine (guanine (G) or adenine (A)), ultimately creating a very
stable glycosidic covalent bond in the cyclization reaction (Fig. 1).
Structural studies indicate that the presence of the cyclopurine
lesion in double-stranded DNA perturbs helix twist and base pair
stacking [5,6]. Consistent with the structural results, cPu lesions
are corrected by nucleotide excision repair (NER) [7,8], which is
unusual because the vast majority of oxidative DNA base lesions
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are repaired by base excision repair (BER) [9]; however, the
mechanistic steps involved in recognition and verification of a cPu
lesion by the NER machinery are not well understood. Biochem-
ical and cellular studies demonstrate that cPu lesions can interfere
with replication [10], inhibit gene expression [7], perturb
transcription factor binding to cognate recognition sequences
[11], and induce transcriptional mutagenesis [12], leading
researchers to investigate their role in disease pathology. Xero-
derma pigmentosum (XP) Group C and Cockayne syndrome (CS)
Group A patient keratinocytes [13,14] and tissues of CSB
knockout mice [15] contained cPu lesions after exposure to low
dose ionizing radiation and tissues from CSB knockout mice. It is
hypothesized that cPu lesions are involved in XP neurological
disease [16]. Furthermore, the stability of cPu base damage in vivo
is supported by observations that under controlled environmental
conditions, cPu lesions accumulate with age in wild-type mice
compared to young mice, and also in congenic progeroid Ercc12/
D mice deficient in the XPF-ERCC1 endonuclease implicated in
NER [17].
While the effects of cPu lesions on the functions of DNA
polymerases [18–22], DNA nucleases [19,23,24], and RNA
polymerase II [7] have been determined, there have been no
studies on the impact of cPu damage on DNA unwinding enzymes
known as helicases. Helicases represent a prominent class of
proteins in cellular nucleic acid metabolism that are important in
not only DNA replication and transcription, but also DNA repair,
recombination, and chromosome segregation; moreover, a num-
ber of genetic disorders characterized by age-related symptoms
and cancer are linked to mutations in helicase genes [25].
Covalent or noncovalent DNA modifications that alter helicase
function are thought to play a role in processes involving
replication stress, DNA damage signaling, and DNA repair [26].
In terms of eukaryotic NER, the XPD helicase is believed to play
an instrumental role in DNA damage verification that is necessary
for subsequent steps to process and replace the damaged DNA
with correct nucleotides [27,28]. Because helicases are now widely
recognized as key enzymes in processes that are either directly
affected by DNA damage or are themselves implicated in the DNA
damage response, we have carefully examined the potential effects
of cPu lesions on the DNA unwinding function of helicases which
play a role in human disease. Our findings from biochemical
studies with purified recombinant DNA helicases and defined
DNA substrates harboring a site- and strand-specific cPu lesion
provide the first evidence for their unique and wide ranging effects
on DNA helicases that are highly likely to encounter the abundant
and stable oxidized base damage.
Materials and Methods
Recombinant DNA helicase proteins
Recombinant human FANCJ [29], DDX11 (ChlR1) [30],
RECQ1 [31], WRN [32], E. coli (Ec) EcDnaB [33], EcDinG [34],
and Thermoplasma acidophilum (ta) XPD [35] were purified as
previously described. EcRecQ was purchased from Abcam.
Human recombinant BLM protein was kindly provided by Dr.
Ian Hickson (University of Copenhagen). EcUvrD protein was
kindly provided by Drs. Ting Xu and Wei Yang (NIDDK,
National Institutes of Health). Superfamily designation and
polarity for each helicase utilized in this study is provided in
Table 1.
DNA substrates
Cyclo dA and Cyclo dG phosphoramidites were purchased
from Berry & Associates (Dexter, MI). Synthesis and purification
by polyacrylamide gel electrophoresis (PAGE) of oligonucleotides
including those which used cyclo dA or cyclo dG phosphorami-
Figure 1. Conversion of adenine and guanine bases to cyclo dA and cyclo dG bases. A, Formation of 29-deoxyadenosine to (59S) 8,59-cyclo-
29-dA and (59R) 8,59-cyclo-29-dA. B, Formation of 29-deoxyguanosine to (59S) 8,59-cyclo-29-dG and (59R) 8,59-cyclo-29-dG.
doi:10.1371/journal.pone.0113293.g001
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dites for synthesis was performed by Loftstrand Labs (Rockville,
MD). The DNA substrates used were 59-32P-end-labeled partial
duplex forked substrates labeled and annealed as described
previously [36]. The forked substrates contained 59 and 39
single-stranded tails of 41 nucleotide (nt) and a 25 base pair (bp)
duplex region. The sequences of the DNA substrates are provided
in Table S1.
Standard helicase assays
Helicase reactions were carried out in 20 ml volumes which
contained 10 fmol of the forked duplex DNA substrate carrying
the cyclopurine lesion either in the top, bottom, or neither strand.
The reactions were performed using previously described condi-
tions (FANCJ [37], DDX11 (ChlR1) [30], taXPD [35,38],
RECQ1 [31], WRN [32] EcRecQ [31], BLM [39], EcDnaB
[33], EcDinG [34], and EcUvrD [40]). Unless stated otherwise,
each of the helicase reactions were carried out by adding the
indicated concentration of helicase protein to the reaction mixture
followed by incubation at the appropriate temperature for the
specified period of time. FANCJ, DDX11, taXPD, RECQ1,
WRN, Ec RecQ, EcDnaB, EcDinG and EcUvrD were incubated
for 15 min, while BLM was incubated for 30 min. Reactions were
quenched with 20 ml of 2X Stop Buffer, containing 17.5 mM
EDTA, 0.6% SDS, 0.02% bromophenol blue, 0.02% xylene
cyanol and 10-fold excess of unlabeled oligonucleotide which
contained the same sequence as the labeled strand. The unlabeled
oligonucleotide was added to prevent reannealing. The quenched
helicase reaction mixture samples were electrophoresed on non-
denaturing 12% polyacrylamide (19:1 acrylamide-bisacrylamide)
gels, visualized using a PhosphorImager, and quantified with
ImageQuant Sofware.
Sequestration helicase assays
For helicase sequestration experiments, FANCJ (9.6 nM) or
RECQ1 (8.8 nM) was preincubated for 3 min at 30uC or 37uC,
respectively, with ATP (2 mM) and the indicated amounts of
unlabeled forked duplex competitor DNA substrates containing
the cdA lesion in the top strand, bottom strand, or neither strand.
Subsequently, 10 fmol of radiolabeled 19 bp forked duplex, also
known as the tracker substrate [41], was added to the mixture and
incubated for an additional 10 min at 30uC (FANCJ) or 37uC
(RECQ1). The helicase reactions were then quenched and
resolved on 12% polyacrylamide gels and visualized as described
under ‘‘Standard helicase assays’’.
Protein trap kinetic helicase assays
For protein trap kinetic helicase assays, FANCJ (0.6 nM),
DDX11 (1 nM), EcUvrD (1 nM), and RECQ1 (7 nM) were
preincubated for 3 min at 24uC with 5 nM of the radiolabeled
forked duplex DNA substrate carrying the cyclo dA lesion in the
top, bottom, or neither strand. After 3 min, ATP (2 mM) and
500 nM oligo dT200 (to serve as protein trap) was added
simultaneously to the reaction mixture and incubated at 30uC or
37uC. Aliquots (20 ml) of the reaction mixture were quenched at
10-sec intervals with 2X Stop Buffer containing a 10-fold excess of
unlabeled oligonucleotide with the same sequence as the labeled
strand. Products of helicase reaction mixtures were then resolved
on 12% polyacrylamide gels and visualized as described under
‘‘Standard helicase assays’’.
Results
Up to this point, there has been no assessment of the effect of
cPu base damage on DNA unwinding by any helicase. Given that
cPu lesions arising from oxidative stress are believed to be fairly
abundant [2,16,17,42,43], interfere with DNA replication and
transcription, and play a prominent role in mutagenesis and
human disease, we undertook a systematic investigation of the
effect of cPu on DNA unwinding by purified recombinant DNA
helicases from different classifications based on sequence homol-
ogy (Table 1). The DNA substrates used for this study are
composed of partially complementary single-stranded oligonucle-
otides containing a single cPu (dA or dG) in either the top or
bottom strand within the double-stranded region of a forked
duplex. Nine bp reside between the 41-nucleotide single-stranded
tails and the site of the cPu adduct and 15 bp reside between the
lesion and blunt duplex end on the opposite side of the DNA
substrate (Table S1). The control substrate consisted of the same
oligonucleotides except there was no cPu lesion present in either
strand.
Effects of a cyclopurine lesion on DNA unwinding by
RecQ helicases under multi-turnover conditions
We began with the human RecQ DNA helicase BLM
implicated in the hereditary chromosomal instability disorder
Bloom Syndrome, and also the human RECQ1 DNA helicase
which is not yet reported to be genetically linked to a human
disease but thought to play a role in cancer suppression [44]. BLM
unwound the control DNA substrate and the substrate with the
cyclo dA (Fig. 2A) or cyclo dG (Fig. 2C) lesion in the top (non-
translocating) strand similarly and in a protein concentration
dependent manner. The substrate with the cyclo dA (Fig. 2A, B)
or cyclo dG (Fig. 2C, D) lesion in the bottom (translocating)
strand was poorly unwound, especially for the cyclo dG adduct in
which only 2% substrate was unwound compared to nearly 40%
of the control substrate or substrate with the non-translocating
strand cyclo dG lesion.
RECQ1 was inhibited by the cyclo dA in the translocating
strand, showing nearly a four-fold reduced level of helicase
activity at the 9 nM RECQ1 concentration where 80% of the
control substrate as well as the substrate with the lesion in the
non-translocating strand was unwound, compared to only 20%
Table 1. DNA Helicases used in this study.
Superfamily Helicases Polarity
1 EcUvrD 39 to 59
2 BLM, RECQ1, WRN, EcRecQ 39 to 59
EcDinG, DDX11, FANCJ, taXPD 59 to 39
4 EcDnaB 59 to 39
doi:10.1371/journal.pone.0113293.t001
Effects of Cyclopurine Base Lesions on DNA Helicases
PLOS ONE | www.plosone.org 3 November 2014 | Volume 9 | Issue 11 | e113293
of the substrate with the cyclo dA in the translocating strand
(Fig. 2E, F). RECQ1 was also similarily inhibited by the cyclo
dG substrates, although the differences were less dramatic
compared to cyclo dA (Fig. 2G, H). We also tested another
human RecQ helicase, WRN which is implicated in Werner
Syndrome [45]. Analysis of reaction products from ATP-
dependent WRN helicase assays revealed partial inhibition by
the cyclo dA in the translocating strand (Fig. 3A, B), but not to
the extent as observed for BLM or RECQ1 helicase. EcRecQ
helicase was also affected by the cyclo dA in a strand-specific
manner, showing inhibition only when the adduct was
positioned in the translocating strand (Fig. 3C, D). Collective-
ly, the results from DNA unwinding assays with human BLM,
WRN, RECQ1, and EcRecQ demonstrated that the RecQ
helicases were inhibited by the cPu to different extents when the
lesion resided in the helicase translocating strand of the forked
duplex DNA molecule.
A cyclopurine lesion does not inhibit DNA unwinding by
Superfamily 1 or 4 DNA helicases under multi-turnover
conditions
Our observations that a single cyclopurine residing in the
duplex was able to inhibit unwinding by all the RecQ helicases
tested led us to ask what the effect of a cyclopurine would be on
DNA unwinding by EcUvrD, a SF1 bacterial helicase implicated
in NER and mismatch repair [46]. Here it is relevant that the
major contacts between SF1 helicases and DNA are believed to be
with the bases via hydrophobic interactions in contrast to SF2
helicase in which electrostatic interactions between the ionic side
chains of amino acids in the helicase protein and the negatively
charged sugar-phosphate backbone prevail [47]. Surprisingly,
EcUvrD was resistant to any detectable inhibition by the
cyclopurine adduct residing in either the translocating or non-
translocating strands of the DNA substrate (Fig. 4A, B).
Figure 2. Effect of a site- and strand-specific cyclopurine lesion on BLM or RECQ1 helicase activity. Helicase reactions were carried out
by incubating the indicated BLM or RECQ1 concentrations with 0.5 nM forked duplex DNA that contained a cyclopurine lesion in the top strand
(nontranslocating-Cyclo T), bottom strand (translocating-Cyclo B), or neither strand (Control) at 37uC for 15 min (RECQ1) or 30 min (BLM) under
standard helicase assay conditions described in the Materials and Methods. A, BLM unwinding of undamaged and cyclo dA damaged DNA substrates.
Lane 1, heat-denatured DNA substrate control; lane 2, no enzyme control; lanes 3–7, indicated concentrations of BLM. B, Quantification of BLM
helicase activity on cdA substrates with error bars. C, BLM unwinding of undamaged and cyclo dG damaged DNA substrates. Lane 1, no enzyme
control; lanes 2–6, indicated concentrations of BLM, lane 7 heat-denatured DNA substrate control. D, Quantification of BLM helicase activity on cdG
substrates with error bars. E, RECQ1 unwinding of undamaged and cyclo dA damaged DNA substrates. Lane 1, no enzyme control; lanes 2–9,
indicated concentrations of RECQ1; lane 10, heat-denatured DNA substrate control. F, Quantification of RECQ1 helicase activity on cdA substrates
with error bars. G, RECQ1 unwinding of undamaged and cyclo dG damaged DNA substrates. Lane 1, no enzyme control; lanes 2–9, indicated
concentrations of RECQ1; lane 10, heat-denatured DNA substrate control. H, Quantification of RECQ1 helicase activity on cdG substrates with error
bars.
doi:10.1371/journal.pone.0113293.g002
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We next tested the SF4 DNA helicase EcDnaB, a hexameric
ring-like helicase that is responsible for unwinding complementary
strands at the replication fork in E. coli. EcDnaB unwinds forked
duplex DNA by inserting one strand within the donut hole of the
hexamer and extruding the other strand outside the central
channel [48]. Therefore, it is believed that the replicative helicase
unwinds duplex DNA by a fundamentally different mechanism
from a number of DNA repair helicases that operate as monomers
or dimers. Experimental studies with EcDnaB and the forked
duplex substrates containing the cyclo dA lesion demonstrated that
EcDnaB, like the SF1 helicase EcUvrD, was unaffected by the
cyclopurine residing in either the translocating or non-translocat-
ing strands (Fig. 4C, D). Based on these results, we conclude that
the sensitivity of SF2 RecQ helicases to a single cyclopurine lesion
residing in the duplex is not generally observed by representative
DNA helicases from SF1 or SF4.
Effects of a cyclopurine lesion on DNA unwinding by Fe-S
cluster helicases under multi-turnover conditons
We next tested the E. coli Fe-S cluster helicase, DinG. EcDinG
was resistant to the cyclo dA lesion in either strand (Fig. 4E, F).
Also tested were three Fe-S cluster DNA helicases important for
chromosomal stability and implicated in genetic diseases: DDX11
(ChlR1) linked to Warsaw Breakage syndrome [49], archaeal
Thermoplasma acidophilum XPD (taXPD), whose human homo-
logue is linked to Xeroderma Pigmentosum [50], and FANCJ
linked to Fanconi Anemia and associated with breast cancer [51].
The control undamaged DNA substrate was unwound by DDX11
in a protein concentration–dependent manner, achieving 60–80%
substrate unwound at the highest protein concentrations (Fig. 5A,
C). The presence of a cyclo dA lesion in either the top or bottom
strand did not inhibit DDX11 helicase activity throughout the
protein titration. In fact, DDX11 unwinding of the substrate with
cyclo dA in the bottom (non-translocating) strand was slightly
better than the control substrate or the substrate with the lesion in
the top strand (Fig. 5B). Similar observations were made for
DDX11 helicase activity on the forked duplex substrate series with
the cyclo dG lesion (Fig. 5D).
The modest effects of a cyclopurine seen with EcDinG and
DDX11 led us to investigate how taXPD might behave when it
encounters the cycloadduct damage. This question was particu-
larly interesting to us because taXPD is believed to play a critical
role in DNA damage verification during a relatively early step of
NER [50]. Given the biochemical evidence that cPu is a substrate
for the NER pathway [7,52], we investigated the ability of taXPD
to unwind forked duplex substrates with cyclo dA in the top
(translocating) or bottom (non-translocating) strands. As shown in
Fig. 5E, F, taXPD was strongly inhibited by the cyclo dA in the
non-translocating strand. Similar behavior with taXPD was also
seen with the cyclo dG substrates (Fig. 5G, D). At 40 nM taXPD,
less than 10% of the forked duplex with cyclo dA in the non-
translocating strand was unwound compared to 60% of the control
forked duplex or the substrate with cyclo dA in the translocating
strand.
A series of experiments were also performed with FANCJ
helicase. FANCJ unwound the DNA substrates in a protein
concentration-dependent manner in the 15-min incubation.
However, in this case there was markedly less unwinding by
FANCJ of the DNA substrate harboring the cyclo dA (Fig. 6A, B)
or cyclo dG (Fig. 6C, D) in the top (translocating) strand.
Throughout the FANCJ protein titration range of 0.15–2.4 nM,
there was consistently a 2- to 3-fold better unwinding of the control
undamaged DNA substrate compared to the substrate with either
cyclo dA or cyclo dG in the helicase translocating strand. Based on
these results, we conclude that the Fe-S cluster helicases are
differentially affected by the cyclopurine lesions, with taXPD being
impeded by either cyclo dA or cyclo dG in the non-translocating
strand, inhibition of FANCJ helicase activity by the translocating
strand cyclo dA or cyclo dG lesion, and no effect of the
cyclopurine lesion on DDX11 or EcDinG.
Sequestration studies with SF2 helicases and forked
duplex competitor DNA harboring a cyclopurine lesion
Previously, we observed that certain forms of DNA damage to
the base (e.g., thymine glycol) [53] or sugar-phosphate backbone
[41] resulted in helicase sequestration by the lesion. To address if
this is the case for a cyclopurine, helicase sequestration experi-
Figure 3. Effect of a site- and strand-specific cyclopurine lesion on WRN or EcRecQ helicase activity. Helicase reactions of 20 ml were
carried out by incubating the appropriate WRN or EcRecQ concentrations with 0.5 nM forked duplex DNA that contained a cyclopurine lesion in the
top strand (nontranslocating-Cyclo T), bottom strand (translocating-Cyclo B), or neither strand (Control) at 37uC for 15 min under standard helicase
assay conditions described in the Materials and Methods. A, WRN unwinding of undamaged and cyclo dA damaged DNA substrates. lane 1, heat
denatured DNA substrate control, lane 2 no enzyme control, lane 3–9, indicated concentrations of WRN. B, Quantification of WRN helicase activity on
cdA substrates with error bars. C, EcRecQ unwinding of undamaged and cyclo dA damaged DNA substrates. Lane 1, no enzyme control; lanes 2–9,
indicated concentrations of EcRecQ; lane 10, heat-denatured DNA substrate control. D, Quantification of EcRecQ helicase activity on cdA substrates
with error bars.
doi:10.1371/journal.pone.0113293.g003
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ments were performed to evaluate if FANCJ (59 to 39 helicase) or
RECQ1 (39 to 59 helicase) was differentially trapped during
unwinding of DNA substrate molecules containing the cyclo dA
lesion in the translocating versus non-translocating strand. If the
helicase is sequestered when it encounters the cyclo dA in the
strand it is predominantly translocating, then the enzyme would be
less available to unwind a forked duplex tracker substrate added
subsequently to the reaction mixture. A schematic for the
experimental procedure is shown in Fig. 7A. Throughout the
competitor DNA titration range, FANCJ helicase activity on the
tracker substrate was inhibited to a significantly greater extent
when the helicase was preincubated with the unlabeled forked
duplex harboring a cyclo dA lesion in the top (translocating) strand
compared to the control undamaged forked substrate (Fig. 7B,
D). For example, FANCJ was able to only unwind 44% of the
tracker substrate when the helicase was preincubated with
2.5 fmol of the forked duplex containing the cyclo dA adduct in
the translocating strand whereas 98% of the tracker substrate was
unwound when FANCJ was preincubated with the undamaged
forked duplex. At this same amount of competitor DNA
containing cyclo dA in the non-translocating strand, FANCJ was
able to unwind 82% of the tracker substrate. Using 5 fmol of
competitor DNA containing the cdA lesion in the translocating
strand, only 15% of the tracker substrate was unwound by FANCJ.
At this same level of competitor DNA with no damage, FANCJ
unwound 53% of the tracker substrate. An intermediate level of
FANCJ helicase activity on the tracker substrate was observed
when FANCJ was preincubated with the competitor DNA
containing the cdA in the non-translocating strand.
In contrast to the experimental results for FANCJ, sequestration
experiments performed with RECQ1 demonstrated that the cyclo
dA adduct positioned in either the bottom (translocating) or top
(non-translocating) strand had no discernible effect on the ability
of RECQ1 to unwind the tracker substrate compared to
preincubation with the control undamaged forked duplex
(Fig. 7C, E). Thus, despite the finding that RECQ1 helicase
activity is inhibited by the cyclo dA in the translocating strand,
RECQ1 is not trapped by the lesion. This would suggest that when
RECQ1 becomes blocked by the lesion, it may dissociate from the
Figure 4. Effect of a site- and strand-specific cyclopurine lesion on EcUvrD, EcDnaB or EcDinG helicase activity. Helicase reactions were
carried out by incubating the appropriate EcUvrD, EcDnaB or EcDinG concentrations with 0.5 nM forked duplex DNA that contained a cyclopurine
lesion in the top strand (nontranslocating-Cyclo T), bottom strand (translocating-Cyclo B), or neither strand (Control) at 37uC for 15 min under
standard helicase assay conditions described in the Materials and Methods. A, EcUvrD unwinding of undamaged and cyclo dA damaged DNA
substrates. Lane 1, no enzyme control; lanes 2–9, indicated concentrations of EcUvrD; lane 10, heat-denatured DNA substrate control. B,
Quantification of EcUvrD helicase activity on cdA substrates with error bars. C, EcDnaB unwinding of undamaged and cyclo dA damaged DNA
substrates. Lane 1, no enzyme control; lanes 2–9, indicated concentrations of EcDnaB; lane 10, heat-denatured DNA substrate control. D,
Quantification of EcDnaB helicase activity on cdA substrates with error bars. E, EcDinG unwinding of undamaged and cyclo dA damaged DNA
substrates. Lane 1, heat-denatured DNA substrate control; lane 2, no enzyme control; lanes 3–10, indicated concentrations of EcDinG. F,
Quantification of EcDinG helicase activity on cdA substrates with error bars.
doi:10.1371/journal.pone.0113293.g004
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DNA and become available to bind and unwind the tracker
substrate.
Protein trap kinetic helicase assays with cyclopurine
substrate to simulate single-turnover conditions
To further reexamine the effect of a cyclopurine lesion on
helicase activity, we performed kinetic assays with a protein trap to
stimulate single turnover conditions (Fig. 8A). FANCJ (0.6 nM),
DDX11 (1 nM), RECQ1 (7 nM), or EcUvrD (1 nM) were allowed
to bind the 5 nM forked duplex substrate containing the cyclo dA
lesion in the top, bottom, or neither strand. Helicase reactions
were initiated by the simultaneous addition of ATP and 500 nM
oligo dT200 which served as a protein trap to bind helicases free in
solution, helicases that dissociated from the DNA substrate, or
helicases that completed unwinding of the forked duplex and
dissociated from the single-stranded unwound products during the
reaction incubation phase. Reaction mixture samples were
removed at 10-sec intervals to establish initial linear rates of
DNA unwinding by FANCJ, DDX11, RECQ1, and EcUvrD
(Fig. 8B, 8C, 8D, 8E). Under these conditions, we determined
that FANCJ unwound the control undamaged forked duplex
substrate at a rate of 0.12 bp sec-1 FANCJ monomer-1 (Fig. 9).
The forked duplex substrate with cyclo dA in the top, translocating
strand was unwound at a rate of 0.012 bp sec-1 FANCJ monomer-1,
a 10-fold slower kinetics compared to the control substrate. In
contrast to these results for FANCJ, the rate of DDX11 helicase
activity was only reduced 1.4-fold by the translocating strand cyclo
dA (Fig. 9). The forked duplex with cyclo dA in the bottom, non-
translocating strand was unwound relatively efficiently compared to
the control substrate for both FANCJ and DDX11. Like the Fe-S
cluster helicases, the rates of DNA unwinding under single-turnover
conditions for the 39 to 59 helicases EcUvrD and RECQ1 were only
affected by cyclo dA in the translocating strand, (which in these
cases would be the bottom strand) (Fig. 9); however, the inhibition
by cyclo dA was greater for RECQ1 (4.5-fold) compared to EcUvrD
(2.5-fold). Based on these results, we conclude that a single cyclo dA
lesion in the helicase translocating strand of the 25-bp forked duplex
substrate significantly slowed down FANCJ and RECQ1 unwinding
but only modestly affected DDX11 and EcUvrD.
Figure 5. Effect of a site- and strand-specific cyclopurine lesion on DDX11 or taXPD helicase activity. Helicase reactions of 20 ml were
carried out by incubating the appropriate DDX11 or taXPD concentrations with 0.5 nM forked duplex DNA that contained a cyclopurine lesion in the
top strand (translocating-Cyclo T), bottom strand (nontranslocating-Cyclo B), or neither strand (Control) at 37uC, for 15 min under standard helicase
assay conditions described in the Materials and Methods. A, DDX11 unwinding of undamaged and cyclo dA damaged DNA substrates. Lane 1, no
enzyme control; lanes 2–9, indicated concentrations of DDX11; lane 10, heat-denatured DNA substrate control. B, Quantification of DDX11 helicase
activity on cdA substrates with error bars. C, DDX11 unwinding of undamaged and cyclo dG damaged DNA substrates. Lane 1, no enzyme control;
lanes 2–9, indicated concentrations of DnaB; lane 10, heat-denatured DNA substrate control. D, Quantification of DDX11 helicase activity on cdG
substrates with error bars. E, taXPD unwinding of undamaged and cyclo dA damaged DNA substrates. Lane 1, heat-denatured DNA substrate control;
lane 2, no enzyme control; lanes 3–10, indicated concentrations of taXPD. F, Quantification of taXPD helicase activity on cdA substrates with error
bars. G, taXPD unwinding of undamaged and cyclo dG damaged DNA substrates. Lane 1, heat-denatured DNA substrate control; lane 2, no enzyme
control, lanes 3–10, indicated concentrations of taXPD. H, Quantification of taXPD helicase activity on cdG substrates with error bars.
doi:10.1371/journal.pone.0113293.g005
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Discussion
The strong ability of cPu lesions to block replication and
transcription, coupled with their accumulation with aging or
progeria in mice, has compelled researchers to understand how
cPu lesions exert their cytotoxic effects and how efficiently they are
detected and corrected by the cellular DNA repair machinery.
Their structural perturbation to the DNA double helix is similar to
that of the UV-induced photoproduct cyclobutane pyrimidine
dimer (CPD) [54,55], which may help to explain why the
Figure 6. Effect of a site- and strand-specific cyclopurine lesion on FANCJ helicase activity. Helicase reactions were carried out by
incubating the appropriate FANCJ concentrations with 0.5 nM forked duplex DNA that contained a cyclopurine lesion in the top strand
(translocating-Cyclo T), bottom strand (nontranslocating-Cyclo B), or neither strand (Control) at 30uC for 15 min under standard helicase assay
conditions described in the Materials and Methods. E, FANCJ unwinding of undamaged and cyclo dA damaged DNA substrates. Lane 1, no enzyme
control; lanes 2–9 indicated concentrations of FANCJ; lane 10, heat- denatured DNA substrate control. F, Quantification of FANCJ helicase activity on
cdA substrates with error bars. G, FANCJ unwinding of undamaged and cyclo dG damaged DNA substrates. lane 1, no enzyme control; lanes 2–9,
indicated concentrations of FANCJ; lane 10, heat- denatured DNA substrate control. H, Quantification of FANCJ helicase activity on cdG substrates
with error bars.
doi:10.1371/journal.pone.0113293.g006
Figure 7. Sequestration of FANCJ, but not RECQ1, by cyclo dA. A, Schematic of sequestration assay. Sequestration assays were performed
with 9.6 nM FANCJ or 8.8 nM RECQ1 and the indicated concentrations of the competitor DNA forked duplex at 30uC (FANCJ) or 37uC (RECQ1) under
sequestration assay conditions described in the Materials and Methods. B and C, FANCJ (B) or RECQ1 (C) unwinding of undamaged 19 bp tracker DNA
substrate after incubation with unlabeled forked duplex DNA molecules that contained cyclo dA in the top, bottom, or neither strand. D and E,
Quantification of FANCJ and RECQ1 helicase activity from representative sequestration experiments shown in panels B and C, respectively.
doi:10.1371/journal.pone.0113293.g007
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oxidatively induced cPu is a substrate of NER [7,52]. In addition,
a recent study suggests that cdA adducts found at 39 termini of
double-strand breaks can be removed by human Apurinic
Endonuclease 1 (APE1), suggesting an alternative pathway for
cleansing genomic cPu lesions [24]. Due to their distinctive
biological effects as well as their impressive chemical stability and
distorting effects on the DNA helix, we set out to assess in a
systematic manner the effects of cyclo dA or cyclo dG adducts on
DNA unwinding catalyzed by a panel of helicases, a number of
which are defective in hereditary disorders and are implicated in
pathways required to preserve genomic stability. These efforts
have led us to conclude that the effects of cyclopurine lesions on
helicase-catalyzed DNA unwinding are of quite a broad range,
and to some extent not easily classified according to helicase family
or even within the same species of conserved helicase proteins.
The RecQ helicases (human BLM, RECQ1, WRN, and EcRecQ)
behaved in the most predictable manner in which the cPu lesion
residing in the translocating strand was found to be inhibitory to
DNA unwinding, whereas there was little to no effect of the cPu in
the non-translocating strand on helicase function. In contrast, the
cPu lesion exerted non-uniform effects on DNA unwinding by Fe-
S cluster helicases that varied widely in terms of strand-specificity
and damage recognition among those helicases tested (FANCJ,
ChlR1 (DDX11), taXPD, and EcDinG). Finally, under multi-
turnover conditions DNA unwinding by the classic E. coli DNA
repair helicase UvrD (which is believed to unwind double-stranded
DNA as a homo-dimer [56]) or the replicative hexameric ring-like
helicase EcDnaB [57] was not affected in any significant manner
by the cPu lesion irrespective of strand residence.
In order to further examine the effect that cPu had on helicase
activity, rates of unwinding for select helicases were conducted
under single-turnover conditions. The SF2 Fe-S cluster helicase
FANCJ is strongly inhibited by the cyclopurine lesion, a result that
is consistent with the strand-specific inhibition observed under the
multi-turnover conditions. In contrast, the rate of DNA unwinding
by the Fe-S cluster helicase DDX11 is only modestly affected by
the cyclopurine damage, a result that is also consistent with what
was observed under multi-turnover conditions. Thus, DDX11
possesses an intrinsic ability to unwind and bypass the cyclopurine,
even in the translocating strand, without invoking the requirement
for additional helicase molecules to load on the same substrate and
help stalled DDX11 helicase molecule translocate forward. In the
case of 39 to 59 helicases, SF1 helicase EcUvrD is detectably
affected by the translocating strand cyclopurine under single-
turnover conditions, whereas the enzyme fully tolerated the lesion
under multi-turnover conditions. These results suggest that the
Figure 8. Protein trap kinetics assay to measure FANCJ, DDX11, RECQ1, and EcUvrD rates of unwinding DNA substrates with cyclo
dA. Reactions were performed under protein trap kinetic assay kinetics conditions described in the Materials and Methods. A, Schematic of protein
trap kinetics helicase assay. B, Quantification of FANCJ helicase activity on cdA DNA substrates. C, Quantification of DDX11 helicase activity on cdA
DNA substrates. D, Quantification of RECQ1 helicase activity on cdA DNA substrates. E, Quantification of EcUvrD helicase activity on cdA DNA
substrates.
doi:10.1371/journal.pone.0113293.g008
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Figure 9. Protein trap kinetic rates for FANCJ, DDX11, RECQ1, and EcUvrD. Rates of unwinding were calculated for each helicase on
undamaged DNA substrates and DNA substrates containing a cyclo dA damage in the translocating or non-translocating strand. Rates were
determined based on experimental data from Figure 8.
doi:10.1371/journal.pone.0113293.g009
Figure 10. The accumulation of cyclopurine lesions in genomic DNA can cause replication errors or blockage leading to deleterious
effects on the fidelity of DNA synthesis and maintenance of genomic stability which have negative outcomes for human health. The
functions of certain DNA helicases can be adversely affected by cyclopurines and other forms of DNA damage which potentially impair helicase-
dependent DNA damage response and repair pathways. See text for details.
doi:10.1371/journal.pone.0113293.g010
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ability of EcUvrD to efficiently unwind the DNA substrate with
the translocating strand cyclopurine lesion in a protein concen-
tration manner under multi-turnover conditions may be in part
due to the loading of more than a single functional helicase
molecule on the DNA substrate during the reaction incubation
period. In contrast, the 39 to 59 helicase RECQ1 is more
negatively affected in its ability to unwind the DNA substrate with
the translocating strand cyclopurine lesion under either single-
turnover or multi-turnover conditions. Thus, inhibition of both
RECQ1 and FANCJ stalling by the cyclopurine lesion in the
translocating strand is not efficiently overcome by increasing the
number of helicase molecules in solution.
The selective deterrence of DNA unwinding by the RecQ
helicases when the cPu lesion resided in the translocating strand is
interesting in light of recent experimental findings that BLM [58]
and Arabidopsis RecQ homologs [59] have the ability to switch
strands upon encountering undamaged double-stranded DNA and
effectively translocate on the opposite strand away from the
duplex. Based on the strand-switching model, it could be suggested
that when RecQ helicase molecules encounter a helix-distorting
lesion such as cPu, a population of helicase molecules may switch
strands and translocate on the opposite strand away from the
lesion, enabling the unwound strands to reanneal behind it.
Although it is unknown if a DNA lesion causes the acceleration of
RecQ strand-switching, it seems probable that strand-specific
inhibition of DNA unwinding by a RecQ helicase caused by an
adduct such as cPu would increase the probability of the helicase
to undergo a strand-switching event. From a biological perspec-
tive, cPu lesions are likely to modulate the functional roles of RecQ
helicases which are generally believed to involve sensing DNA
damage at the replication fork or facilitating the processing of
DNA ends or recombinant DNA molecules that arise in early or
later steps of double-strand break repair [25].
FANCJ was the sole Fe-S cluster helicase tested that displayed a
sensitivity similar to that of the RecQ helicases in which inhibition
was observed only when the cPu adduct resided in the helicase
translocating strand. To our knowledge, strand-switching by
FANCJ or any Fe-S helicase for that matter has not been
examined, leaving in question the mechanistic basis for inhibition
of FANCJ helicase by the cPu lesion. Unlike most, if not all RecQ
helicases, FANCJ does not efficiently catalyze strand annealing of
pre-existing complementary single-stranded DNA molecules [37].
If helicase-catalyzed strand annealing is a signature event of
strand-switching by a RecQ helicase, FANCJ is likely to behave
differently when it encounters helicase roadblocks. Consistent with
this notion, FANCJ, but not RECQ1, was partially sequestered by
the cPu. Protein trap kinetic assays demonstrated that the rate of
FANCJ helicase activity was reduced 10-fold by the translocating
strand cyclo dA. In contrast, the sequence-related ChlR1 and
EcDinG helicases fully tolerated the cPu lesion in either the
translocating or non-translocating strands. Therefore, the Fe-S
cluster helicases ChlR1 and EcDinG are likely to unwind damaged
DNA by a mechanism that is distinguishable from FANCJ.
Previously, the effects of more classic NER lesions such as the
UV photoproduct CPD have been examined for their effects on
DNA binding and unwinding by various archaeal XPD helicases
[50,55,60,61]. In the current study, we analyzed the effect of a cPu
lesion on taXPD helicase activity. taXPD was inhibited by the cPu
lesion residing in the helicase non-translocating strand, but
unaffected by the cPu in the helicase translocating strand.
Recently, it was shown that Ferroplasma acidarmanus XPD
(faXPD) utilizes its conserved Fe-S cluster domain as a damage
sensor pocket, which scans for lesions when translocating on a
DNA substrate [50]. Biophysical studies suggest that taXPD
utilizes its damage sensor function in order to recognize distinct
NER-type lesions at different positions when translocating on a
DNA bubble substrate [55]. taXPD preferentially recognized a
bulky fluorescein lesion residing in the translocating strand,
whereas it detected a CPD lesion located in the non-translocating
strand more readily. It was proposed that the fluorescein adduct
may distort the helix in a manner that directly impedes passage of
single-stranded DNA through the central hole of the helicase
protein. In contrast, the CPD lesion may pass through the central
hole, but likely comes into contact with the damage sensor when
present on the non-translocating strand and thus inhibits taXPD
[55]. Based on our results, it is plausible that the cPu lesion is
recognized by taXPD in a similar fashion to a CPD lesion.
It is also possible that the differences in sensitivity of Fe-S cluster
helicases to DNA damage such as a cPu adduct could be due to
other mechanisms. Recent experimental evidence from the Barton
lab suggested that DNA repair proteins (Sulfolobus acidocaldarius
XPD and Endonuclease III) with redox active Fe-S clusters can
utilize charge transport along the DNA double helical molecules as
a means for detecting DNA lesions and recruiting other repair
proteins [62]. It remains to be seen to what extent the cPu lesion
affects electron transport along the axis of the DNA double helix,
and what role this may play in helicase function or recruitment of
other DNA damage repair proteins. Interestingly, the aforemen-
tioned APE1 has redox capability which is thought to be important
for cell growth and differentiation [63], but it is not well
understood if the redox function plays a role in the recognition
or excision of oxidized bases.
The noted effects of cPu lesions on DNA helicases has
implications for how these adducts may have an impact on
replication and other areas of DNA metabolism. In a recent study,
it was found that cPu adducts inhibit DNA replication and lead to
increased mutation frequencies at the lesion sites through base pair
transversions [22]. Certain translesion synthesis (TLS) polymerases
can promote efficient bypass of the cPu adduct, but can cause
mutations at the lesion sites [21,22]. Interestingly, FANCJ was
reported to promote TLS pol eta-dependent bypass of UV-
induced DNA damage [64], raising the possibility that the helicase
may facilitate TLS past cPu adducts. It is plausible that a helicase
like FANCJ which was inhibited by a cPu lesion may help to
recruit a TLS polymerase to facilitate DNA synthesis. The ability
of cellular DNA replication and repair machinery, including DNA
damage response and repair pathways dependent on DNA
helicases, to suppress replication errors induced by cyclopurines
and other oxidative DNA lesions has important consequences for
aging and age-related diseases (Fig. 10). It is believed that stem
cell function is impaired by age-dependent accumulation of
damaged DNA [65]. Extrinsic and intrinsic factors can induce
molecular effectors such as reactive oxygen species to cause
genomic and epigenomic changes in stem cells that debilitate
function, leading to abnormal differentiated cells which in turn
contribute to tissue dysfunction and aging [66]. Because cPu
adducts have been shown to accumulate in an age-dependent
manner [17], it is reasonable to speculate that their metabolism
will have important consequences for stem cell dysfunction with
aging.
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